Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
Carmine Zoccali(Biogem), Rainer H. Böger(Universität Hamburg), Ignazio Bellanuova(University of Catania), Francesca Mallamaci(Società Italiana di Nefrologia), Isabella Fermo(Vita-Salute San Raffaele University), Alessandro Cataliotti(University of Catania), Stefanie M. Bode‐Böger(Otto-von-Guericke-Universität Magdeburg), Frank Benedetto(Metabolism and Renal Physiology), Lorenzo Malatino(University of Catania), Jürgen C. Frölich, Giovanni Tripepi(National Research Council)
Cited by 1,092
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877
External validation of prognostic models: what, why, how, when and where?
|Clinical Kidney Journal|2020|808